Showing results (21-30 of 34) with videos related to

Sort By:
Pageof 4
Molecular Cancer Therapeutics|December 15, 2017
Antitumor Activity of Entrectinib, a Pan-TRK, ROS1, and ALK Inhibitor, in <i>ETV6-NTRK3</i>-Positive Acute Myeloid LeukemiaKristen M Smith, Patrick C Fagan, Elena Pomari, et al.
Studies in Health Technology and Informatics|May 17, 2025
Beyond Model Performance: Information Needs for an Algorithmovigilance Sociotechnical SystemMegan E Salwei, Sharon Davis, Laurie L Novak, et al.
Medrxiv : the Preprint Server for Health Sciences|June 29, 2026
Adverse Childhood Experiences and Growth Outcomes in Childhood: A Longitudinal EHR-Based StudySamuel A Palmer, Cathy Shyr, Theodore Morley, et al.
Diagnostic and Prognostic Research|September 7, 2025
Predicting venous thromboembolism among hospitalized adults: a protocol for development and validation of an implementable real-time prognostic modelHenry J Domenico, Benjamin F Tillman, Shari L Just, et al.
Pain|September 30, 2016
Differential expression of systemic inflammatory mediators in amputees with chronic residual limb painAlexander Chamessian, Thomas Van de Ven, Thomas Buchheit, et al.
Prenatal Diagnosis|February 10, 2015
Prenatal detection of structural cardiac defects and presence of associated anomalies: a retrospective observational study of 1262 fetal echocardiogramsFionnuala Mone, Colin Walsh, Cecelia Mulcahy, et al.
Cancer Biology & Therapy|March 18, 2010
Oral delivery of PND-1186 FAK inhibitor decreases tumor growth and spontaneous breast to lung metastasis in pre-clinical modelsColin Walsh, Isabelle Tanjoni, Sean Uryu, et al.
Cancer Research|January 13, 2011
p190RhoGEF (Rgnef) promotes colon carcinoma tumor progression via interaction with focal adhesion kinaseHong-Gang Yu, Ju-Ock Nam, Nichol L G Miller, et al.
Cancer Biology & Therapy|March 18, 2010
PND-1186 FAK inhibitor selectively promotes tumor cell apoptosis in three-dimensional environmentsIsabelle Tanjoni, Colin Walsh, Sean Uryu, et al.
Methods in Molecular Biology (Clifton, N.J.)|February 26, 2014
Microfluidic-based manufacture of siRNA-lipid nanoparticles for therapeutic applicationsColin Walsh, Kevin Ou, Nathan M Belliveau, et al.
Pageof 4